Target intelligence / Profile preview

Guanine-rich DNA sequences (G-rich DNA)

Target
G-rich DNA
Molecular classification
Nucleic acid, Non-canonical DNA structure
01

Overview

Guanine-rich DNA sequences are genomic regions characterized by a high density of guanine nucleotides, which are capable of folding into non-canonical four-stranded structures known as G-quadruplexes (G4s). These sequences are non-randomly distributed throughout the human genome, clustering in functional regions such as telomeres, ribosomal DNA, and the promoter regions of potent oncogenes like MYC, BCL2, and KRAS (Rhodes & Lipps, 2015, Nucleic Acids Res). Biologically, these structures act as regulatory elements that influence DNA replication, gene transcription, and telomere protection. In the context of disease, G-rich regions are frequently associated with cancer progression and neurodegenerative disorders, such as C9orf72-linked amyotrophic lateral sclerosis, where repeat expansions form toxic structures (DeJesus-Hernandez et al., 2011, Neuron). Therapeutic intervention typically involves small molecules that stabilize G-quadruplexes to inhibit oncogene expression or traditional alkylating agents like cisplatin that bind guanine to cause lethal DNA damage (Dasari & Bernard Tchounwou, 2014, Eur J Pharmacol). However, targeting these sites presents significant challenges regarding selectivity and the risk of systemic genotoxicity.

Other names
G-quadruplexG4 DNAG-rich regionsGuanine-rich DNATelomeric DNA
02

Mechanism of action

Drugs targeting these regions typically act by stabilizing non-canonical structures like G-quadruplexes to inhibit transcription and replication, or by forming covalent adducts and cross-links with guanine bases to induce DNA damage and apoptosis (Dasari & Bernard Tchounwou, 2014; Rhodes & Lipps, 2015).

03

Biological functions

Transcription regulationTelomere maintenanceDNA replicationEpigenetic regulation
04

Disease associations

CancerAmyotrophic lateral sclerosisFrontotemporal dementia
05

Safety considerations

GenotoxicityMyelosuppressionSecondary malignanciesOff-target DNA damage
06

Interacting drugs

Cisplatin

4 more in the full profile.

07

Biomarkers

G-quadruplex densityTelomere lengthMicrosatellite instability

Beyond the preview

Go deeper on Guanine-rich DNA sequences (G-rich DNA).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guanine-rich DNA sequences (G-rich DNA).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call